CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2151.85-27.7 (-1.27 %)
PREV CLOSE () 2179.55
OPEN PRICE () 2166.15
BID PRICE (QTY) 2150.10 (16)
OFFER PRICE (QTY) 2151.80 (16)
VOLUME 8579
TODAY'S LOW / HIGH ()2144.50 2177.55
52 WK LOW / HIGH ()2115.5 3050
NSE2147.70-31.1 (-1.43 %)
PREV CLOSE() 2178.80
OPEN PRICE () 2178.90
BID PRICE (QTY) 2146.90 (80)
OFFER PRICE (QTY) 2147.70 (372)
VOLUME 475099
TODAY'S LOW / HIGH() 2144.00 2180.80
52 WK LOW / HIGH ()2115.1 3054.8
ChairmanRamesh Juneja
Managing DirectorRajeev Juneja
Company SecretaryHitesh Kumar Jain
Non Executive Independent DirectorT P Ostwal
Vijaya Sampath
Bharat Anand
Vivek Kalra
Whole Time DirectorSheetal Arora
Satish Kumar Sharma
Incorporation Year : 03-07 1991

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,
Delhi-110020 .

Phone : 011-46846700 / 47476600

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85180.59-87.07 (-0.10%)
NIFTY26009.85-37.10 (-0.14%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI